Literature DB >> 25111156

The introduction of dengue vaccine may temporarily cause large spikes in prevalence.

A Pandey1, J Medlock2.   

Abstract

A dengue vaccine is expected to be available within a few years. Once vaccine is available, policy-makers will need to develop suitable policies to allocate the vaccine. Mathematical models of dengue transmission predict complex temporal patterns in prevalence, driven by seasonal oscillations in mosquito abundance. In particular, vaccine introduction may induce a transient period immediately after vaccine introduction where prevalence can spike higher than in the pre-vaccination period. These spikes in prevalence could lead to doubts about the vaccination programme among the public and even among decision-makers, possibly impeding the vaccination programme. Using simple dengue transmission models, we found that large transient spikes in prevalence are robust phenomena that occur when vaccine coverage and vaccine efficacy are not either both very high or both very low. Despite the presence of transient spikes in prevalence, the models predict that vaccination does always reduce the total number of infections in the 15 years after vaccine introduction. We conclude that policy-makers should prepare for spikes in prevalence after vaccine introduction to mitigate the burden of these spikes and to accurately measure the effectiveness of the vaccine programme.

Entities:  

Keywords:  vaccination effectiveness

Mesh:

Substances:

Year:  2014        PMID: 25111156      PMCID: PMC9507178          DOI: 10.1017/S0950268814001939

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  18 in total

1.  The rainbow bridge: Hamiltonian limits and resonance in predator-prey dynamics.

Authors:  A A King; W M Schaffer
Journal:  J Math Biol       Date:  1999-11       Impact factor: 2.259

Review 2.  Dengue: a continuing global threat.

Authors:  Maria G Guzman; Scott B Halstead; Harvey Artsob; Philippe Buchy; Jeremy Farrar; Duane J Gubler; Elizabeth Hunsperger; Axel Kroeger; Harold S Margolis; Eric Martínez; Michael B Nathan; Jose Luis Pelegrino; Cameron Simmons; Sutee Yoksan; Rosanna W Peeling
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

Review 3.  Dengue vaccines: progress and challenges.

Authors:  Beth-Ann G Coller; David E Clements
Journal:  Curr Opin Immunol       Date:  2011-04-21       Impact factor: 7.486

4.  Dengue vaccine development: a 75% solution?

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2012-09-11       Impact factor: 79.321

5.  Comparing vector–host and SIR models for dengue transmission.

Authors:  Abhishek Pandey; Anuj Mubayi; Jan Medlock
Journal:  Math Biosci       Date:  2013-12       Impact factor: 2.144

6.  Disease extinction and community size: modeling the persistence of measles.

Authors:  M J Keeling; B T Grenfell
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

7.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Authors:  Ananda Nisalak; Timothy P Endy; Suchitra Nimmannitya; Siripen Kalayanarooj; Usa Thisayakorn; Robert M Scott; Donald S Burke; Charles H Hoke; Bruce L Innis; David W Vaughn
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

8.  Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever.

Authors:  Yoshiro Nagao; Katia Koelle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

9.  Dengue shock.

Authors:  Senaka Rajapakse
Journal:  J Emerg Trauma Shock       Date:  2011-01

10.  Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity.

Authors:  Nicholas G Reich; Sourya Shrestha; Aaron A King; Pejman Rohani; Justin Lessler; Siripen Kalayanarooj; In-Kyu Yoon; Robert V Gibbons; Donald S Burke; Derek A T Cummings
Journal:  J R Soc Interface       Date:  2013-07-03       Impact factor: 4.118

View more
  4 in total

1.  Cost-Effectiveness of Dengue Vaccination Programs in Brazil.

Authors:  Eunha Shim
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

2.  Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model.

Authors:  Eunha Shim
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

3.  After the honeymoon, the divorce: Unexpected outcomes of disease control measures against endemic infections.

Authors:  Brandon Hollingsworth; Kenichi W Okamoto; Alun L Lloyd
Journal:  PLoS Comput Biol       Date:  2020-10-19       Impact factor: 4.475

4.  Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines.

Authors:  Eunha Shim
Journal:  Am J Trop Med Hyg       Date:  2016-09-06       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.